Crashing the Stent Party

摘要

CONOR MEDSYSTEMS Inc.is developing a new breed of stent that may have the power to swipe large swaths of business from rivals such as Johnson & Johnson and Boston Scientific Corp.But the company's chief executive officer,Dr.Frank Litvack,has a controversial past,and there are thorny questions about potential conflicts of interest and litigation that could torpedo its fortunes.